Vifor Pharma to Provide Akebia’s Anemia Therapy Vadadustat to Group of US Dialysis Clinics
News Vifor Pharma Group has obtained exclusive rights to sell Akebia Therapeutics‘ kidney-disease-related anti-anemia treatment vadadustat (AKB-6548) to Fresenius Medical Care dialysis clinics in the United States. The licensing agreement will kick in ... Read more